Stanley SA, Grant SS, Kawate T, et al. Identification of novel inhibitors of M. tuberculosis growth using whole cell based high-throughput screening. ACS Chem Biol. 2012;7(8):1377-84. doi:10.1021/cb300151m
Schreiber SL. Organic synthesis toward small-molecule probes and drugs. Proc Natl Acad Sci U S A. 2011;108(17):6699-702. doi:10.1073/pnas.1103205108
Haining N, Pulendran B. Identifying gnostic predictors of the vaccine response. Curr Opin Immunol. 2012;24(3):332-6. doi:10.1016/j.coi.2012.03.010
Schreiber SL. Organic chemistry: Molecular diversity by design. Nature. 2009;457(7226):153-4. doi:10.1038/457153a
Mulrooney CA, Lahr DL, Quintin MJ, et al. An informatic pipeline for managing high-throughput screening experiments and analyzing data from stereochemically diverse libraries. J Comput Aided Mol Des. 2013;27(5):455-68. doi:10.1007/s10822-013-9641-y
Schreiber SL. Stuart Schreiber: biology from a chemist’s perspective. Interview by Joanna Owens. Drug Discov Today. 2004;9(7):299-303. doi:10.1016/S1359-6446(04)03063-6
Bhatia SN, Ingber DE. Microfluidic organs-on-chips. Nat Biotechnol. 2014;32(8):760-72. doi:10.1038/nbt.2989
Schreiber SL. Target-oriented and diversity-oriented organic synthesis in drug discovery. Science. 2000;287(5460):1964-9.